Microbiology & Infectious Diseases

Ensitrelvir reduces risk of COVID-19 in household contacts when administered within 72 hours of symptom onset.

UKHSA data reveal that imported dengue cases in England, Wales, and Northern Ireland have reached their highest level since surveillance began in 2009.

New evidence suggests that a 7-day course of antibiotics is as effective as a 14-day regimen for most patients with Gram-negative bloodstream infections.

New findings highlight the potential of once-yearly intramuscular lenacapavir for PrEP, offering a long-acting alternative that could reduce barriers to HIV prevention.

The ECDC reports an alarming 10% rise in childhood tuberculosis cases across Europe, stressing the urgent need for enhanced prevention, diagnosis, and treatment.

A first-in-human study evaluating a novel long-acting injectable antiretroviral therapy has provided promising early results on its safety and pharmacokinetics.

COVID-19 caused a significant decline in life expectancy and years of life lost across 18 European countries from 2020–2022.

The new CRISPR-Cascade assay eliminates the need for nucleic acid amplification, enabling highly sensitive detection of pathogens within minutes.